Clinical Trial Update: Single Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia [Phase 2, Phase 3]

View source ↗

Summary

This document provides an update on a clinical trial evaluating arsenic trioxide as a single-agent treatment for newly diagnosed acute promyelocytic leukemia, s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Promyelocytic Leukemia

Drugs mentioned

• Arsenic Trioxide (arsenic trioxide)

Snippet

Sponsor: Christian Medical College, Vellore, India | Conditions: Acute Promyelocytic Leukemia | Phase 2, Phase 3 | Status: UNKNOWN